Page last updated: 2024-10-24

negative regulation of antifungal innate immune response

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of an antifungal innate immune response. [GO_REF:0000058, GOC:dph, GOC:TermGenie, PMID:22470487]

Negative regulation of antifungal innate immune response is a complex process that involves multiple cellular and molecular mechanisms aimed at dampening the host's immune response to fungal infections. This regulation is crucial to prevent excessive inflammation and tissue damage, which can be detrimental to the host. Here's a detailed breakdown of the process:

1. **Recognition of Fungal Pathogens:** The innate immune system initially detects fungal pathogens through pattern recognition receptors (PRRs) expressed on immune cells. These PRRs recognize specific fungal components like β-glucan, chitin, and mannan.

2. **Activation of Signaling Pathways:** Upon recognition, PRRs trigger downstream signaling pathways, primarily involving the Toll-like receptor (TLR) and C-type lectin receptor (CLR) pathways. These pathways activate transcription factors like NF-κB and MAP kinases, leading to the production of pro-inflammatory cytokines and chemokines.

3. **Recruitment of Immune Cells:** The pro-inflammatory cytokines attract immune cells like neutrophils, macrophages, and dendritic cells to the site of infection. These cells contribute to fungal clearance through phagocytosis, the release of antimicrobial peptides, and the production of further cytokines.

4. **Negative Regulation Mechanisms:**
- **Cytokine Antagonists:** Specific cytokines like IL-10 and TGF-β act as negative regulators by suppressing the production of pro-inflammatory cytokines like TNF-α and IL-6. This downregulation limits the extent of inflammation and tissue damage.
- **Apoptosis of Immune Cells:** Immune cells, particularly neutrophils, undergo apoptosis (programmed cell death) after phagocytosis or exposure to fungal components. This prevents excessive inflammation and the release of damaging contents from dying cells.
- **Immune Cell Exhaustion:** Prolonged exposure to fungal antigens can lead to immune cell exhaustion, characterized by reduced cytokine production and impaired effector functions. This mechanism limits the duration of the immune response.
- **Myeloid-Derived Suppressor Cells (MDSCs):** These cells suppress the activation of T cells, thereby dampening the adaptive immune response and preventing excessive inflammation.
- **Regulatory T Cells (Tregs):** Tregs are immune cells that actively suppress the activity of other immune cells, contributing to the resolution of inflammation and preventing autoimmune reactions.

5. **Resolution of Inflammation:** The negative regulation mechanisms ultimately lead to a controlled resolution of the inflammatory response, promoting tissue repair and restoration of homeostasis.

6. **Immune Memory:** While the innate immune response is primarily responsible for the initial antifungal defense, the adaptive immune response plays a crucial role in generating immunological memory, allowing for more rapid and efficient responses to subsequent fungal infections.

Overall, the negative regulation of antifungal innate immune response is a finely tuned process that ensures an effective response against fungal pathogens while simultaneously preventing excessive inflammation and tissue damage. The balance between activation and suppression of the immune system is critical for successful host defense against fungal infections.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Ubiquitin carboxyl-terminal hydrolase 15A ubiquitin carboxyl-terminal hydrolase 15 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y4E8]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
celastrolmonocarboxylic acid;
pentacyclic triterpenoid
anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
acetyl isogambogic acidacetyl isogambogic acid: structure in first source